Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Time to commencement of effective treatment in patients with drug-resistant tuberculosis diagnosed in the Torres Strait / Papua New Guinea cross-border region

J’Belle Foster, Diana Mendez, Ben J. Marais, Dunstan Peniyamina, Emma S. McBryde
doi: https://doi.org/10.1101/2022.01.16.22269389
J’Belle Foster
1James Cook University College of Medicine and Dentistry, Townsville, Queensland, Australia
2Torres and Cape Tuberculosis Control Unit, Thursday Island, Queensland, Australia
3Australian Institute of Tropical Health and Medicine, Townsville, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jbelle.foster{at}my.jcu.edu.au
Diana Mendez
3Australian Institute of Tropical Health and Medicine, Townsville, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben J. Marais
4Sydney Institute for Infectious Diseases and Biosecurity, Westmead, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dunstan Peniyamina
5Cairns Tropical Public Health Service, Cairns, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma S. McBryde
1James Cook University College of Medicine and Dentistry, Townsville, Queensland, Australia
2Torres and Cape Tuberculosis Control Unit, Thursday Island, Queensland, Australia
3Australian Institute of Tropical Health and Medicine, Townsville, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

All data produced in the present study are not publicly available. Due to the nature of this research, restrictions apply to the availability of these data. The data custodian of Queensland Health data produced in the study is and remains the Director-General and/or the Chief Executive of the relevant Hospital and Health Service on behalf of the State of Queensland.

Back to top
PreviousNext
Posted December 19, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Time to commencement of effective treatment in patients with drug-resistant tuberculosis diagnosed in the Torres Strait / Papua New Guinea cross-border region
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Time to commencement of effective treatment in patients with drug-resistant tuberculosis diagnosed in the Torres Strait / Papua New Guinea cross-border region
J’Belle Foster, Diana Mendez, Ben J. Marais, Dunstan Peniyamina, Emma S. McBryde
medRxiv 2022.01.16.22269389; doi: https://doi.org/10.1101/2022.01.16.22269389
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Time to commencement of effective treatment in patients with drug-resistant tuberculosis diagnosed in the Torres Strait / Papua New Guinea cross-border region
J’Belle Foster, Diana Mendez, Ben J. Marais, Dunstan Peniyamina, Emma S. McBryde
medRxiv 2022.01.16.22269389; doi: https://doi.org/10.1101/2022.01.16.22269389

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)